Skip to main content

Education

  • MD, Royal College of Surgeons, Dublin, Ireland
  • PhD, University of Oslo (2014)

Score

  • Postdoctoral fellow at the Unit for Clinical Research, Clinic for Rheumatology, Outpatient Clinic and Research, Diakonhjemmet Hospital

Field of interest

  • Psoriatic arthritis
  • Spondyloarthritis
  • Randomized controlled trials
  • Epidemiology

Email

Telephone

visiting address

Diakonhjemmet hospital
Forstanderboligen
Reidar Kobros vei 8
0370 Oslo

Postal address

Diakohjemmet hospital
PO Box 23 Vinderen
0319 Oslo

Projects

WP1 - Optimized medical interventions

NOR Sprint

Follow-up of newly diagnosed patients with psoriatic arthritis with and without imaging

Project Manager:
Siri Lillegraven
WP6 - Dechiphering long-term outcomes

SPACE

Early detection of spondyloarthritis

Project Manager:
Karen Minde Fagerli

Publications

Publications taken from the National Science Archive (NVA):

Can rheumatologists unequivocally diagnose axial spondyloarthritis in patients with chronic back pain of less than 2 years duration? Primary outcome of the 2-year SPondyloArthritis Caught Early (SPACE) cohort

Mary Lucy Marques, Sofia Ramiro, Miranda van Lunteren, Rosalinde Anne Stal, Robert BM Landewé, Marleen van de Sande


Annals of the Rheumatic Diseases

2024

Patient-reported outcomes in axial spondyloarthritis and psoriatic arthritis patients treated with secukinumab for 24 months in daily clinical practice

Sara Nysom Christiansen, Simon Horskjær Rasmussen, Marion Pons, Brigitte Michelsen, Bente Glintborg, Bjorn Gudbjornsson


Seminars in Arthritis & Rheumatism

2024

Patient-Reported Outcomes (PROs) and PRO Remission Rates in 12,262 Biologic-Naïve Patients With Psoriatic Arthritis Treated With Tumor Necrosis Factor Inhibitors in Routine Care

Lykke M. Ørnbjerg, Kathrine Rugbjerg, Stylianos Georgiadis, Simon H. Rasmussen, Lennart Jacobsson, Anne G. Loft


Journal of Rheumatology

2024

Sex Differences in the Effectiveness of First-Line Tumor Necrosis Factor Inhibitors in Psoriatic Arthritis: Results From the European Spondyloarthritis Research Collaboration Network

Pasoon Hellamand, Marleen GH van de Sande, Lykke M. Ørnbjerg, Thomas Klausch, Kari K. Eklund, Heikki Relas


Arthritis & Rheumatology

2023

One-Third of European Patients With Axial Spondyloarthritis Achieve Pain Remission With Routine Care Tumor Necrosis Factor Inhibitor Treatment

Lykke Midtbøll Ørnbjerg, Kathrine Rugbjerg, Stylianos Georgiadis, Simon Horskjær Rasmussen, Ulf Lindström, Karel Pavelka


Journal of Rheumatology

2023

Discontinuation rate of sulfasalazine, leflunomide and methotrexate due to adverse events in a real-life setting (NOR-DMARD)

Mielnik Pawel, Joseph Sexton, Karen Minde Fagerli, Gunnstein Bakland, Yi Hu, Eirik Kristianslund


Rheumatology - Advances in Practice (Rheumap)

2023

Treatment Response to Tumor Necrosis Factor Inhibitors and Methotrexate Monotherapy in Adults With Juvenile Idiopathic Arthritis: Data From NOR-DMARD

Imane Bardan, Karen Minde Fagerli, Joseph Sexton, Tore Kristian Aaserud Kvien, Gunnstein Bakland, Mielnik Pawel


Journal of Rheumatology

2022

The impact of a csDMARD in combination with a TNF inhibitor on drug retention and clinical remission in axial spondyloarthritis

Michael Nissen, Bénédicte Delcoigne, Daniela Di Giuseppe, Lennart Jacobsson, Merete Lund Hetland, Adrian Ciurea


Rheumatology

2022

Measuring quality of life of patients with axial spondyloarthritis for economic evaluation

Monica Hernandez Alava, Allan Wailoo, Georgios Chrysanthou, Filipe Barcelos, Floris A. Van Gaalen, Helena Santos


RMD Open

2022

Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15,332 patients with psoriatic arthritis. Data from the EuroSpA collaboration

Ulf Lindström, Daniela Di Giuseppe, Bénédicte Delcoigne, Bente Glintborg, Brukhard Möller, Adrian Ciurea


Annals of the Rheumatic Diseases

2021

Malignancy and mortality rates in patients with severe psoriatic arthritis requiring tumor-necrosis factor alpha inhibition: results from the British Society for Rheumatology Biologics Register

Karen Minde Fagerli, Lianne Kearsley-Fleet, Louise K. Mercer, Kath Watson, Jon Packham, Deborah PM Symmons


Rheumatology

2019

Frequency of Impaired Spinal Mobility in Patients with Chronic Back Pain Compared to Patients with Early Axial Spondyloarthritis

Camilla Fongen, Hanne Dagfinrud, Inger Jorid Berg, Sofia Ramiro, Floris van Gaalen, Robert Landewé


Journal of Rheumatology

2018

Long-term persistence of TNF-inhibitor treatment in patients with psoriatic arthritis. Data from the British Society for Rheumatology Biologics Register

Karen Minde Fagerli, Lianne Kearsley-Fleet, Kath D. Watson, Jon Packham, Deborah PM Symmons, Kimme L. Hyrich


RMD Open

2018

Biological treatment in ankylosing spondylitis in the Nordic countries during 2010-2016: a collaboration between five biological registries

Bente Glintborg, Ulf Lindström, Kalle Aaltonen, Eirik Kristianslund, Björn Guðbjörnsson, Katerina Chatzidionysiou


Scandinavian Journal of Rheumatology

2018

Impact of replacing radiographic sacroiliitis by magnetic resonance imaging structural lesions on the classification of patients with axial spondyloarthritis

Pauline AC Bakker, Rosaline van der Berg, Manouk de Hooge, Miranda van Lunteren, Zineb Ez-Zaitouni, Karen Minde Fagerli


Rheumatology

2018

Imaging of the sacroiliac joints is important for diagnosing early axial spondyloarthritis but not all-decisive

Zineb Ez-Zaitouni, Robert Landewé, Miranda van Lunteren, Pauline AC Bakker, Karen Minde Fagerli, Roberta Ramonda


Rheumatology

2018

The yield of a positive MRI of the spine as imaging criterion in the ASAS classification criteria for axial spondyloarthritis: Results from the SPACE and DESIR cohorts

Zineb Ez-Zaitouni, Pauline AC Bakker, Miranda van Lunteren, Manouk de Hooge, Rosaline van den Berg, Monique Reijnierse


Annals of the Rheumatic Diseases

2017

Is the Site of Back Pain Related to the Location of Magnetic Resonance Imaging Lesions in Patients With Chronic Back Pain? Results From the Spondyloarthritis Caught Early Cohort

Manouk de Hooge, Freek de Bruin, Lieke de Beer, Pauline Bakker, Rosaline van den Berg, Sofia Ramiro


Arthritis care & research

2017

Do depression and anxiety reduce the likelihood of remission in rheumatoid arthritis and psoriatic arthritis? Data from the prospective multicentre NOR-DMARD study

Brigitte Michelsen, Eirik Kristianslund, Joseph Sexton, Hilde Berner Hammer, Karen Minde Fagerli, Elisabeth Lie


Annals of the Rheumatic Diseases

2017

Discordance between tender and swollen joint count as well as patient's and evaluator's global assessment may reduce likelihood of remission in patients with rheumatoid arthritis and psoriatic arthritis: data from the prospective multicentre NOR-DMARD study

Brigitte Michelsen, Eirik Kristianslund, Hilde Berner Hammer, Karen Minde Fagerli, Elisabeth Lie, Ada Wierød


Annals of the Rheumatic Diseases

2017

Are Additional Tests Needed to Rule Out Axial Spondyloarthritis in Patients Ages 16–45 Years With Short-Duration Chronic Back Pain and Maximally One Spondyloarthritis Feature?

Pauline AC Bakker, Z. Ez-Zaitouni, M. van Lunteren, R. Van den Berg, M de Hooge, Karen Minde Fagerli


Arthritis care & research

2016

Prevalence of degenerative changes of the spine on magnetic resonance images and radiographs in patients aged 16-45 years with chronic back pain of short duration in the Spondyloarthritis Caught Early (SPACE) cohort

F de Bruin, Simone ter Horst, Hans L. Bloem, Rosaline van den Berg, Manouk de Hooge, Floris Van gaalen


Rheumatology

2016

Patients with chronic back pain of short duration from the SPACE cohort: which MRI structural lesions in the sacroiliac joints and inflammatory and structural lesions in the spine are most specific for axial spondyloarthritis?

M de Hooge, R. Van den Berg, Victoria Navarro-Compan, M Reijnierse, F van Galen, Karen Minde Fagerli


Annals of the Rheumatic Diseases

2016

Metric properties of the SPARCC score of the sacroiliac joints-data from baseline, 3-month, and 12-month followup in the SPACEl

Rosaline van den Berg, Manouk de Hooge, Pauline AC Bakker, Floris van Gaalen, Victoria Navarro-Compan, Karen Minde Fagerli


Journal of Rheumatology

2015

Signal intensity loss of the intervertebral discs in the cervical spine of young patients on fluid sensitive sequences

F de Bruin, S ter Horst, R. Van den Berg, M de Hooge, F van Galen, Karen Minde Fagerli


Skeletal Radiology

2015

Is there a role for sulphasalazine in axial spondyloarthritis in the era of TNF inhibition? Data from the NOR-DMARD longitudinal observational study

Karen Minde Fagerli, Desirée van der Heijde, Marte Schrumpf Heiberg, Ada Wierød, Synnøve Kalstad, Erik Rødevand


Rheumatology

2014

The role of methotrexate co-medication in TNF-inhibitor treatment in patients with psoriatic arthritis: results from 440 patients included in the NOR-DMARD study

Karen Minde Fagerli, Elisabeth Lie, Desirée van der Heijde, Marte S. Heiberg, Åse Lexberg, Erik Rødevand


Annals of the Rheumatic Diseases

2014

Switching between TNF inhibitors in psoriatic arthritis: data from the NOR-DMARD study

Karen Minde Fagerli, Elisabeth Lie, Desirée van der Heijde, Marte Schrumpf, Synnøve Kalstad, Erik Rødevand


Annals of the Rheumatic Diseases

2013

Selecting patients with ankylosing spondylitis for TNF inhibitor therapy: comparison of ASDAS and BASDAI eligibility criteria

Karen Minde Fagerli, Elisabeth Lie, Desirée van der Heijde, Marte Schrumpf, Cecilie Kaufmann, Erik Rødevand


Rheumatology

2012